143 related articles for article (PubMed ID: 36407690)
1. Percutaneous Septal Reduction Therapy in a Patient with Severely Symptomatic Hypertrophic Obstructive Cardiomyopathy: An experience from a tertiary care centre.
Al Lawati H; Nadar SK; Al Riyami AB
Sultan Qaboos Univ Med J; 2022 Nov; 22(4):443-447. PubMed ID: 36407690
[No Abstract] [Full Text] [Related]
2. Septal Ablation for Hypertrophic Obstructive Cardiomyopathy: Transcoronary and Endocardial Approach.
Aksu T; Guler T; Yalin K; Golcuk SE; Ozcan K
Am J Med Sci; 2016 Nov; 352(5):466-471. PubMed ID: 27865293
[TBL] [Abstract][Full Text] [Related]
3. Extended septal myectomy and left ventricular outflow tract intervention for hypertrophic obstructive cardiomyopathy.
Pruna-Guillen R; Ascaso M; Affronti A; Quintana E
Multimed Man Cardiothorac Surg; 2021 Mar; 2021():. PubMed ID: 33691043
[TBL] [Abstract][Full Text] [Related]
4. Percutaneous septal ablation for hypertrophic cardiomyopathy and mid-ventricular obstruction.
Seggewiss H; Faber L
Eur J Echocardiogr; 2000 Dec; 1(4):277-80. PubMed ID: 11916606
[TBL] [Abstract][Full Text] [Related]
5. Percutaneous transluminal septal myocardial ablation in a child with hypertrophic obstructive cardiomyopathy and Noonan syndrome.
Singh H; Kalra R; Keshavamurthy GB; Singh M; Singh C
Congenit Heart Dis; 2008; 3(5):347-51. PubMed ID: 18837814
[TBL] [Abstract][Full Text] [Related]
6. A successful percutaneous closure of ventricular septal defect following septal myectomy in patients with hypertrophic obstructive cardiomyopathy.
Kilicgedik A; Karabay CY; Aung SM; Guler A; Kalayci A; Tasar O; Kirma C
Perfusion; 2012 May; 27(3):253-5. PubMed ID: 22547641
[TBL] [Abstract][Full Text] [Related]
7. A case of hypertrophic obstructive cardiomyopathy complicated by a single coronary artery treated by transcoronary septal ablation.
Hara H; Ishii K; Nakamura M
J Invasive Cardiol; 2006 May; 18(5):234-8. PubMed ID: 16670451
[No Abstract] [Full Text] [Related]
8. The long-term outcomes of transcoronary ablation of septal hypertrophy compared to surgical myectomy in patients with symptomatic hypertrophic obstructive cardiomyopathy.
Samardhi H; Walters DL; Raffel C; Rateesh S; Harley C; Burstow D; Pohlner P; Aroney C
Catheter Cardiovasc Interv; 2014 Feb; 83(2):270-7. PubMed ID: 23873660
[TBL] [Abstract][Full Text] [Related]
9. Sudden death of a case of hypertrophic obstructive cardiomyopathy 19 months after successful percutaneous transluminal septal myocardial ablation.
Hirata K; Wake M; Asato H; Kyushima M; Serizawa Y
Circ J; 2003 Jun; 67(6):559-61. PubMed ID: 12808279
[TBL] [Abstract][Full Text] [Related]
10. "Moving left ventricular obstruction" due to stress cardiomyopathy in a patient with hypertrophic obstructive cardiomyopathy treated with percutaneous transluminal septal myocardial ablation.
Akita K; Maekawa Y; Tsuruta H; Okuda S; Yanagisawa R; Kageyama T; Kawakami T; Kanazawa H; Hayashida K; Yuasa S; Murata M; Jinzaki M; Fukuda K
Int J Cardiol; 2016 Jan; 202():194-5. PubMed ID: 26397409
[No Abstract] [Full Text] [Related]
11. Septal myectomy with a carbon dioxide laser for hypertrophic cardiomyopathy.
Dowling RD; Landreneau RJ; Gasior TA; Ziady GM; Armitage JM
Ann Thorac Surg; 1993 Jun; 55(6):1558-60. PubMed ID: 8512413
[TBL] [Abstract][Full Text] [Related]
12. Endocardial septal ablation for hypertrophic obstructive cardiomyopathy.
Aksu T; Güler TE; Yalın K; Gölcük ŞE; Özcan KS
Turk Kardiyol Dern Ars; 2017 Jan; 45(1):67-72. PubMed ID: 28106021
[TBL] [Abstract][Full Text] [Related]
13. Percutaneous septal ablation in hypertrophic obstructive cardiomyopathy.
Faber L
Eur J Med Res; 2006 Oct; 11(10):423-31. PubMed ID: 17107876
[TBL] [Abstract][Full Text] [Related]
14. [Clinical case of the month. Treatment of obstructive hypertrophic cardiomyopathy by percutaneous septal ablation].
Hoffer E; Boland J
Rev Med Liege; 2002 Jul; 57(7):433-7. PubMed ID: 12233217
[TBL] [Abstract][Full Text] [Related]
15. Role of percutaneous septal ablation in hypertrophic obstructive cardiomyopathy.
Kimmelstiel CD; Maron BJ
Circulation; 2004 Feb; 109(4):452-6. PubMed ID: 14757682
[No Abstract] [Full Text] [Related]
16. Successful percutaneous transluminal septal myocardial ablation through a right superior septal artery for a patient with hypertrophic obstructive cardiomyopathy.
Kurita T; Tsuchikane E; Tanaka N; Suzuki T
Cardiovasc Interv Ther; 2015 Oct; 30(4):377-81. PubMed ID: 25502014
[TBL] [Abstract][Full Text] [Related]
17. [One-year follow-up after echocardiographically-guided percutaneous septal ablation in hypertrophic obstructive cardiomyopathy].
Seggewiss H; Faber L; Ziemssen P; Gleichmann U
Dtsch Med Wochenschr; 2001 Apr; 126(15):424-30. PubMed ID: 11347004
[TBL] [Abstract][Full Text] [Related]
18. Transaortic Chordal Cutting: Mitral Valve Repair for Obstructive Hypertrophic Cardiomyopathy With Mild Septal Hypertrophy.
Ferrazzi P; Spirito P; Iacovoni A; Calabrese A; Migliorati K; Simon C; Pentiricci S; Poggio D; Grillo M; Amigoni P; Iascone M; Mortara A; Maron BJ; Senni M; Bruzzi P
J Am Coll Cardiol; 2015 Oct; 66(15):1687-96. PubMed ID: 26449139
[TBL] [Abstract][Full Text] [Related]
19. An aneurysmal formation of a septal branch after percutaneous septal myocardial ablation.
Sonoda K; Ikeda S; Ohe H; Harada T; Seki M; Kohno S
Intern Med; 2006; 45(10):699-700. PubMed ID: 16778345
[No Abstract] [Full Text] [Related]
20. Endocardial radiofrequency septal ablation - A new option for non-surgical septal reduction in patients with hypertrophic obstructive cardiomyopathy (HOCM)?: A systematic review of clinical studies.
Poon SS; Cooper RM; Gupta D
Int J Cardiol; 2016 Nov; 222():772-774. PubMed ID: 27521556
[No Abstract] [Full Text] [Related]
[Next] [New Search]
